Members
The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. Members represent the private and public sectors and come from diverse geographical locations.
Apply Now Learn More View Core GroupCurrent Members
Name | Organization | Country |
---|---|---|
Rick O'Brien | Switzerland | |
Gilla Kaplan | United States | |
Heinz Moser | Achaogen | United States |
Kolawole Ekanoye | Advocates for Health and Development Initiative | Nigeria |
Joan A. Cayla | Agència de Salut Pública de Barcelona | Spain |
Ahmadul Khan | Ahmadul Hasan Khan | Bangladesh |
Hiromu Kawakubo | Asahi Kasei Chemicals Corporation | Japan |
Robert Wallis | Aurum Institute | South Africa |
Gary Horwith | BARDA | United States |
Simon Tiberi | Barts Healthcare NHS Trust | United Kingdom |
Christopher Locher | Baxalta | United States |
Martin Springsklee | Bayer Healthcare | United States |
Tawanda Gumbo | Baylor University | United States |
Cathy Bansbach | Bill & Melinda Gates Foundation | United States |
Jan Gheuens | Bill & Melinda Gates Foundation | United States |
Ken Duncan | Bill & Melinda Gates Foundation | United States |
Debra Hanna | Bill and Melinda Gates Foundation | United States |
Omar Vandal | Bill and Melinda Gates Foundation | United States |
Peter Warner | Bill and Melinda Gates Foundation | United States |
Khisimuzi Mdluli | Bill and Melinda Gates Medical Research Institute | United States |
Yadav Prasad Joshi | Biodyss and Journal Infection in Developing Countries | France |
Marc Gitzinger | BioVersys AG | Switzerland |
Juan David Guzman | Birkbeck College | United Kingdom |
C. Robert Horsburgh | Boston University School of Public Health | United States |
Shashank Gupta | Brown University | United States |
Jerome Zeldis | Celgene | United States |
Benson Muriuki | Center for the Empowerment Of The Local Herbalist-Celoh Kenya | Kenya |
Sidharth Chopra | Central Drug Research Institute, Lucknow | India |
Martin Dolezal | Charles University in Prague, Faculty of Pharmacy in Hradec Kralove | Czech Republic |
Robert Husson | Children's Hospital Boston/Harvard Medical School | United States |
Masaji Okada | Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center | Japan |
Shreemanta Parida | Clinical Scientist | India |
Regina Osih | Clinton Health Access Initiative | South Africa |
Barry Bunin | Collaborative Drug Discovery | United States |
Anne Lenaerts | Colorado State University | United States |
Mary Jackson | Colorado State University | United States |
Mary Ann de Groote | Colorado State University | United States |
Diane Ordway | Colorado State University | United States |
Josef Jampilek | Comenius University | Slovakia |
Albert Makone | Community Representative; Global Fund (local) | Zimbabwe |
Brian VanderVen | Cornell University | United States |
David Russell | Cornell University | United States |
Hulda Swai | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
Boitumelo Semete | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
Ravishankar Ramachandran | CSIR-Central Drug Research Institute, Lucknow, India | India |
Tanjore Balganesh | CSIR-OSDD | India |
Anneke Hesseling | Desmond Tutu TB Centre | South Africa |
Todd Waldman | Easton Associates | United States |
Neeraj Dhar | École Polytechnique Fédérale de Lausanne (EPFL) | Switzerland |
Kenneth Castro | Emory University | United States |
Yap Boum II | Epicentre/MSF | Uganda |
Jurriaan de Steenwinkel | Erasmus MC | Netherlands |
Wim Vandevelde | European AIDS Treatment Group (EATG); Community Representative | South Africa |
Carol Dukes Hamilton | Family Health International | United States |
Christine Sizemore | Fogarty International Center at NIH | United States |
Maria Freire | Foundation for NIH | United States |
Jing Bao | Frontier Biotechnologies, LLC | United States |
Xuelian Zhang | Fudan University | China |
Doug Lowrie | Fudan University's Shanghai Public Health Clinical Center | China |
Mohammad Hassan Mashori | Fundamental Human Rights & Rural Development Association (FHRRDA) | Pakistan |
Nii Nortey Hanson-Nortey | Ghana Health Service | Ghana |
David Barros | GlaxoSithKline | Spain |
Robert Bates | GlaxoSmithKline | Spain |
Oscar Della Pasqua | GlaxoSmithKline | United Kingdom |
Lluís Ballell | GlaxoSmithKline Tres Cantos | Spain |
Christopher Cooper | Global Alliance for TB Drug Development (TB Alliance) | United States |
Stephen Matlin | Global Forum for Health Research | Switzerland |
Bonita Mangura | Global TB Institute at UMDNJ | United States |
Samir Roy | Government Medical College, Bhavnagar | India |
Muhammad Farooq | Government of Pakistan | Pakistan |
Alick Chimpimo Makiyi | Grassroots Movement for Health and Development (GMHD) | Malawi |
Carole Mitnick | Harvard Medical School | United States |
Matthew Price | Harvard School of Public Health | United States |
Polly Clayden | HIV i-Base | United Kingdom |
James Frincke | Hollis Eden Pharmaceuticals | United States |
Ann Ginsberg | IAVI | United States |
Brian Robertson | Imperial College London | United Kingdom |
Gail Cassell | Infectious Disease Research Institute (IDRI) | United States |
Allen Casey | Infectious Disease Research Institute (IDRI) | United States |
Tanya Parish | Infectious Disease Research Institute (IDRI) | United States |
Iain Old | Innovative Medicines for TB (iM4TB) | Switzerland |
Pere-Joan Cardona | Institut Germans Trias i Pujol (IGTP) | Spain |
Stewart Cole | Institut Pasteur | Switzerland |
Nicolas Willand | Institut Pasteur Lille | France |
Kevin Pethe | Institut Pasteur-Korea | South Korea |
Scott Franzblau | Institute for Tuberculosis Research, University of Illinois at Chicago | United States |
Hugo Cesar Gramajo | Instituto de Biologia Molecular y Celular de Rosario | Argentina |
Kanury Rao | International Centre for Genetic Engineering & Biotechnology-New Delhi | India |
Dorothy Odhiambo | International Community of Women Living with HIV in Kenya ( ICW-K) | Kenya |
Chris Edlin | iThemba Pharmaceuticals | South Africa |
Roger Moses | iThemba Pharmaceuticals | United Kingdom |
Koen Andries | Janssen | Belgium |
Tado Shimao | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
Noroi Doi | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
William Bishai | Johns Hopkins School of Medicine | United States |
Ying Zhang | Johns Hopkins University | United States |
Gyanu Lamichhane | Johns Hopkins University | United States |
Eric Nuermberger | Johns Hopkins University | United States |
Richard Chaisson | Johns Hopkins University Center for TB Research | United States |
Petros Karakousis | Johns Hopkins University School of Medicine | United States |
Shichun Lun | Johns Hopkins University School of Medicine | United States |
Anil Koul | Johnson and Johnson | Belgium |
Sergey Koren | JSC Pharmasyntez | Russia |
Oren Zimhony | Kaplan Medical Center, The School of Medicine Hebrew University | Israel |
Steve Wandiga | KEMRI/CDC | Kenya |
Martin Graham | KinderPharm | United States |
James Love | Knowledge Ecology International (KEI) | United States |
Sang Jae Kim | Korean Institute of Tuberculosis | South Korea |
Philip Hipskind | Lgenia | United States |
Richard White | London School of Hygiene and Tropical Medicine | United Kingdom |
Michael Hoelscher | Ludwig-Maximilians-University | Germany |
Galyna Kutsyna | Luhansk State Medical University | Ukraine |
Rajender Kamboj | Lupin Limited | India |
Prasit Palittapongarnpim | Mahidol University | Thailand |
Renaud Boulanger | McGill University | Canada |
David McNeeley | Medical Service Corportation International (MSCI) | United States |
Tarek Aboul-Fadl | Medicinal Chemistry, Assiut University | Egypt |
Maggie McCammon | Michigan Economic Development Corporation | United States |
Dhanji Rajani | Microcare Laboratory | India |
Sonja Henne | MSF | Tunisia |
Asaad Khalid Ahmed | National Center for Research | Sudan |
Nino Lomtadze | National Center for Tuberculosis and Lung Diseases | Georgia |
Nelly Solomonia | National Center for Tuberculosis and Lung Diseases | Georgia |
Shekhar Mande | National Centre for Cell Science | India |
Jim Boyce | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Laura Via | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Francisco Leyva | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Barbara Laughon | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Sharon Williams | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Gail Tauscher | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Mamodikoe Makhene | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Marina Protopopova | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Clifton Barry | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Rogelio Hernandez Pando | National Institute of Medical Sciences and Nutrition, Mexico | Mexico |
Liyanage Perera | National Institutes of Health (NIH) | United States |
Helena Boshoff | National Institutes of Health (NIH) | United States |
Andriy Dudnyk | National Medical University of Vinnytsia, Ukraine | Ukraine |
Basharat Khan | National TB Control Programme | Pakistan |
Zahoor Ahmed | National TB Control Programme | Pakistan |
Htay Lwin | National TB Program, Myanmar | Myanmar (Burma) |
Abdifetah Ibrahim Omer | National TB Programme Somalia | Somalia |
Daniela Jabes | NeED Parma | Italy |
Roberto Salvino | No affiliation | Philippines |
Sandeep Saluja | No affiliation | India |
Avishek Anant | Novartis | India |
Manjunatha Ujjini | Novartis Institute for Tropical Diseases | Singapore |
Lawrence Geiter | Otsuka Pharmaceutical Company | United States |
Martin Johan Boeree | PanACEA Consortium and the Radboud University Nijmegen Medical Centre | Netherlands |
Edward Nardell | Partners in Health | United States |
Valerie Flore Donkeng Donfack | Pasteur Center in Cameroon | Cameroon |
Claire Wingfield | PATH | United States |
Chris Dippel | Peloton Partnering, SP | United States |
Nelson Otwoma | Positive Familes Network (+FN) | Kenya |
Teto Fondacaro Mamona | Programme National de Lutte Contre la Tuberculose | Democratic Republic Of Congo (Zaire) |
Khadar Bhatcha | PSG College of Pharmacy | India |
Daniel Zollinger | QareFree | Netherlands |
Dario Scaramuzzi | R-Evolution Group EEIG | Italy |
Bolin Geng | Ra Pharma | United States |
Bob Goldman | RCG Consulting | United States |
Michaela Nielsen | Regulatory Affairs Consultant | United States |
Santiago Ramón García | Research Agency of Aragon (ARAID) | Spain |
Doris Rouse | RTI International | United States |
Florence Bordon-Pallier | Sanofi | France |
Isabelle Cieren-Puiseux | Sanofi | France |
Charles Wells | Sanofi | United States |
Brigitte Demers | Sanofi | France |
Didier Leboulleux | Sanofi | France |
Alexandra Carreau | Sanofi-Adventis R&D | France |
John Szumowski | Santa Clara Valley Medical Center | United States |
Victoria Kasprowicz | SANTHE | South Africa |
Fernando Pavan | Sao Paulo State University, UNESP, Brazil | Brazil |
Jacques Grosset | Scientist | France |
Carol Nacy | Sequella, Inc. | United States |
Leo Einck | Sequella, Inc. | United States |
Prasad Pasam | Shar Technologies Group | India |
KR John | SRM Medical College | India |
Amina Jindani | St. George's, University of London | United Kingdom |
Gerhard Walzl | Stellenbosch University | South Africa |
Edward Berry | SUNY Upstate Medical University | United States |
Gill Black | Sustainable Livelihoods Foundation | South Africa |
Klaus Reither | Swiss Tropical and Public Health Institute | Tanzania |
Cherise Scott | TB Alliance | United States |
Rajneesh Taneja | TB Alliance | United States |
Anna Upton | TB Alliance | United States |
Takushi Kaneko | TB Alliance | United States |
Frances Pappas | TB Alliance | United States |
Christo van Niekerk | TB Alliance | South Africa |
Melvin Spigelman | TB Alliance | United States |
Asghar Arif | TB Association Charsadda Pak | Pakistan |
Dalene von Delft | TB Proof | South Africa |
Jeffery Cirillo | Texas A&M Health Science Center | United States |
William Chamberlin | Texas Tech University Health Sciences Center | United States |
Sanjib Bhakta | The Institute of Structural and Molecular Biology, Birkbeck, University of London | United Kingdom |
Kristina Wallengren | THINK | South Africa |
Erica Lessem | Treatment Action Group | United States |
Mark Harrington | Treatment Action Group | United States |
Ronan O'Toole | Trinity College Dublin | Ireland |
P. R. Narayanan | Tuberculosis Research Centre, Chennai (retired) | India |
Andrew Vernon | U.S. Centers for Disease Control and Prevention (CDC) | United States |
Valerie Mizrahi | UCT-Institute of Infectious Disease and Molecular Medicine | South Africa |
Joshua Wamboga | Uganda Network of AIDS Service Organisations (UNASO) | Uganda |
Joel Freundlich | UMDNJ - New Jersey Medical School | United States |
Amy Bloom | United States Agency for International Development (USAID) | United States |
Mario Raviglione | Università degli Studi di Milano | Switzerland |
Aboubacar Sidiki Daffe | Université Cheikh Anta DIOP | Senegal |
Ibrahim Abubakar | University College London, MRC Clinical Trials Unit | United Kingdom |
Thomas Dick | University in New Jersey UMDNJ-New Jersey Medical School | United States |
Arun Kumar Mishra | University of Birmingham | United Kingdom |
Yossef Av-Gay | University of British Columbia | Canada |
Payam Nahid | University of California, San Francisco | United States |
Gustavo E. Velásquez | University of California, San Francisco | USA |
Jonathan Blackburn | University of Cape Town | South Africa |
Ute Muh | University of Iowa | United States |
Oleg Tsodikov | University of Kentucky | United States |
Parameshwar Makam | University of KwaZulu-Natal | South Africa |
Christopher Sassetti | University of Massachusetts Medical School | United States |
Sylvie Garneau-Tsodikova | University of Michigan | United States |
Anthony Baughn | University of Minnesota | United States |
Bernard Fourie | University of Pretoria | South Africa |
Marcio Dias | University of Sao Paulo | Brazil |
Andreas Diacon | University of Stellenbosch | South Africa |
Bavesh Kana | University of the Witwatersrand/National Health Laboratory Service | South Africa |
David Sherman | University of Washington | United States |
Norbert Heinrich | Universtiy of Munich / PanACEA | Germany |
Shashi Kant | UT Southwestern Medical Center | United States |
Michael Cynamon | VAMC, SUNY, Upstate Medical University | United States |
Tiansheng Wang | Vertex Pharmaceuticals | United States |
Astrid Van der Sar | VU University Medical Center | Netherlands |
Carl Nathan | Weill Cornell Medical College | United States |
Kyu Rhee | Weill Cornell Medical College | United States |
Dirk Schnappinger | Weill Cornell Medical College | United States |
Tamari Trapaidze | Welfare Foundation | Georgia |
Philip Onyebujoh | WHO Regional Office for Africa | Zimbabwe |
Kobina Bosumtwi Dadzie | Wiljok Childaid and Health Organization | Ghana |
Christian Lienhardt | World Health Organization (WHO) | Senegal |
Malgosia Grzemska | World Health Organization (WHO) | Switzerland |
Sang Nae Cho | Yonsei University College of Medicine | South Korea |
Kampasati Satyanarayana | Yuvabharath Society | India |
New Members
The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.
Apply NowQuestions? Contact Us